Market Overview

Dicerna Pharmaceuticals (NASDAQ: DRNA)

16.39 +0.59 (3.73%)

Analyst Ratings

DateResearch FirmActionCurrentPT
5/24/19CitigroupAssumesBuy30.0
2/26/19Cowen & Co.Initiates Coverage OnOutperform
11/28/18Leerink SwannInitiates Coverage OnOutperform24.0
11/06/18B. Riley FBRUpgradesBuy21.0
10/30/18CitigroupMaintainsBuy30.0
9/17/18B. Riley FBRMaintainsNeutral13.5
9/13/18CitigroupInitiates Coverage OnBuy27.0
8/15/18H.C. WainwrightUpgradesBuy
8/09/18Stifel NicolausMaintainsBuy20.0
3/28/18B. Riley FBRInitiates Coverage OnNeutral10.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter